Clinical Trials Directory

Trials / Completed

CompletedNCT03901092

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 PET Scan Interpretation

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
242 (actual)
Sponsor
Avid Radiopharmaceuticals · Industry
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

This study will evaluate the performance of physician readers trained to read flortaucipir-PET (positron emission tomography) scans.

Conditions

Interventions

TypeNameDescription
DRUGflortaucipir F 18No study drug will be administered.

Timeline

Start date
2019-03-26
Primary completion
2019-04-26
Completion
2019-04-26
First posted
2019-04-03
Last updated
2020-09-09
Results posted
2020-08-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03901092. Inclusion in this directory is not an endorsement.

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpret (NCT03901092) · Clinical Trials Directory